Likely active: new deal Oct 2024 Verified 5 Nov 2026
Primetime Partners
Early-stage venture fund that incubates and invests in companies serving older adults and the longevity economy, across healthcare, financial services, consumer and media.
- Type
- VC firm
- Location
- New York, New York, United States
- Stages
- Seed, Series A
- Backs
- Medtech and digital health, B2B software, Fintech
- Sectors
- Healthtech and life sciences, Fintech, AI, Insurtech, Consumer, Media
- Fund size / AUM
- $60M Primetime Partners Fund II (Form D offering, 2024); $71.3M gross private fund assets (Form ADV; private funds: 1, of which venture capital: 1)
- Portfolio mix
- Medtech and digital health 48%; B2B software 17%; Fintech 10%; Consumer apps 7%; Consumer products 7%; Climate and energy 3%; Tech-enabled services 3%; Real assets 3% (n=29)
- Website
- www.primetimepartners.com
Contacts on file
For Primetime Partners, the paid file holds: 4 named decision-makers with roles; how to pitch (the route the firm publishes).
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Notable investments
Rosarium HealthYes HearingHCG Secure
Sources
- adviserinfo.sec.gov/firm/summary/310695
- www.primetimepartners.com
- www.primetimepartners.com/portfolio
- www.sec.gov/Archives/edgar/data/2025221/000202522124000001/
- www.primetimepartners.com/team
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 63 lists
Media investors in New York (20)Series A insurtech investors in the US (23)Series A media investors in the US (36)Series A insurtech investors (40)Seed insurtech investors in the US (41)Series A investors in New York (49)Medtech investors in New York (53)Insurtech venture capital firms in the US (56)Series A media investors (59)Consumer investors in New York (59)Seed insurtech investors (61)Series A medtech investors in the US (76)Series A consumer investors in the US (80)Seed media investors in the US (81)Insurtech investors (88)Fintech investors in New York (98)Healthtech investors in New York (100)Series A medtech investors (125)Seed media investors (125)Seed investors in New York (128)Media venture capital firms in the US (135)SaaS investors in New York (138)Series A fintech investors in the US (145)Series A consumer investors (154)AI investors in New York (159)Series A healthtech investors in the US (164)Media investors (200)Seed medtech investors in the US (205)Seed consumer investors in the US (216)Series A SaaS investors in the US (256)Seed medtech investors (278)Series A AI investors in the US (280)Series A fintech investors (294)Seed consumer investors (331)Consumer venture capital firms in the US (348)Seed fintech investors in the US (349)Medtech venture capital firms in the US (350)Series A investors in the US (372)Series A healthtech investors (401)Seed healthtech investors in the US (437)Venture capital firms in New York (440)Medtech investors (457)Series A SaaS investors (475)Series A AI investors (500)Consumer investors (512)Fintech venture capital firms in the US (525)Seed fintech investors (584)Seed SaaS investors in the US (666)Healthtech venture capital firms in the US (709)Seed AI investors in the US (724)Seed healthtech investors (800)Fintech investors (846)Series A investors (864)Seed SaaS investors (1,010)Seed investors in the US (1,043)SaaS venture capital firms in the US (1,049)Seed AI investors (1,082)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)AI investors (1,576)Seed investors (1,892)Venture capital firms in the US (2,975)